1. Home
  2. WTM vs WGSWW Comparison

WTM vs WGSWW Comparison

Compare WTM & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WTM
  • WGSWW
  • Stock Information
  • Founded
  • WTM 1980
  • WGSWW 2017
  • Country
  • WTM Bermuda
  • WGSWW United States
  • Employees
  • WTM N/A
  • WGSWW N/A
  • Industry
  • WTM Property-Casualty Insurers
  • WGSWW Retail: Computer Software & Peripheral Equipment
  • Sector
  • WTM Finance
  • WGSWW Technology
  • Exchange
  • WTM Nasdaq
  • WGSWW Nasdaq
  • Market Cap
  • WTM N/A
  • WGSWW N/A
  • IPO Year
  • WTM N/A
  • WGSWW N/A
  • Fundamental
  • Price
  • WTM $1,857.20
  • WGSWW $0.20
  • Analyst Decision
  • WTM
  • WGSWW
  • Analyst Count
  • WTM 0
  • WGSWW 0
  • Target Price
  • WTM N/A
  • WGSWW N/A
  • AVG Volume (30 Days)
  • WTM 14.4K
  • WGSWW 39.8K
  • Earning Date
  • WTM 02-07-2025
  • WGSWW 02-18-2025
  • Dividend Yield
  • WTM 0.05%
  • WGSWW N/A
  • EPS Growth
  • WTM N/A
  • WGSWW N/A
  • EPS
  • WTM 89.79
  • WGSWW N/A
  • Revenue
  • WTM $2,354,300,000.00
  • WGSWW $305,450,000.00
  • Revenue This Year
  • WTM N/A
  • WGSWW N/A
  • Revenue Next Year
  • WTM N/A
  • WGSWW N/A
  • P/E Ratio
  • WTM $20.54
  • WGSWW N/A
  • Revenue Growth
  • WTM 8.66
  • WGSWW 50.79
  • 52 Week Low
  • WTM $1,665.71
  • WGSWW $0.17
  • 52 Week High
  • WTM $2,023.00
  • WGSWW $0.29
  • Technical
  • Relative Strength Index (RSI)
  • WTM 47.96
  • WGSWW N/A
  • Support Level
  • WTM $1,835.00
  • WGSWW N/A
  • Resistance Level
  • WTM $1,931.35
  • WGSWW N/A
  • Average True Range (ATR)
  • WTM 25.07
  • WGSWW 0.00
  • MACD
  • WTM 2.91
  • WGSWW 0.00
  • Stochastic Oscillator
  • WTM 41.79
  • WGSWW 0.00

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

Share on Social Networks: